Literature DB >> 32894242

Examination of the Effect of Rare Variants in TREM2, ABI3, and PLCG2 in LOAD Through Multiple Phenotypes.

Claudia Olive1,2, Laura Ibanez1,2, Fabiana H Geraldo Farias1,2, Fengxian Wang1,2, John P Budde1,2, Joanne B Norton1,2,3, Jen Gentsch1,2,3, John C Morris2,3, Zeran Li1,2, Umber Dube1,2, Jorge Del-Aguila1,2, Kristy Bergmann1,2, Joseph Bradley1,2, Bruno A Benitez1,2, Oscar Harari1,2, Anne Fagan4, Beau Ances4, Carlos Cruchaga1,2, Maria Victoria Fernandez1,2.   

Abstract

BACKGROUND: Rare variants in PLCG2 (p.P522R), ABI3 (p.S209F), and TREM2 (p.R47H, p.R62H) have been associated with late onset Alzheimer's disease (LOAD) risk in Caucasians. After the initial report, several studies have found positive results in cohorts of different ethnic background and with different phenotype.
OBJECTIVE: In this study, we aim to evaluate the association of rare coding variants in PLCG2, ABI3, and TREM2 with LOAD risk and their effect at different time points of the disease.
METHODS: We used a European American cohort to assess the association of the variants prior onset (using CSF Aβ42, tau, and pTau levels, and amyloid imaging as endophenotypes) and after onset (measured as rate of memory decline).
RESULTS: We confirm the association with LOAD risk of TREM2 p.R47H, p.R62H and ABI3 p.S209F variants, and the protective effect of PLCG2 p.P522R. In addition, ABI3 and TREM2 gene-sets showed significant association with LOAD risk. TREM2 p.R47H and PLCG2 p.P522R variants were also statistically associated with increase of amyloid imaging and AD progression, respectively. We did not observe any association of ABI3 p.S209F with any of the other AD endophenotypes.
CONCLUSION: The results of this study highlight the importance of including biomarkers and alternative phenotypes to better understand the role of novel candidate genes with the disease.

Entities:  

Keywords:  ABI3; PLCG2; TREM2; endophenotypes; late onset Alzheimer’s disease; progression

Year:  2020        PMID: 32894242      PMCID: PMC7927150          DOI: 10.3233/JAD-200019

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  53 in total

1.  A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3.

Authors:  Pablo Cingolani; Adrian Platts; Le Lily Wang; Melissa Coon; Tung Nguyen; Luan Wang; Susan J Land; Xiangyi Lu; Douglas M Ruden
Journal:  Fly (Austin)       Date:  2012 Apr-Jun       Impact factor: 2.160

2.  The rare TREM2 R47H variant exerts only a modest effect on Alzheimer disease risk.

Authors:  Basavaraj V Hooli; Antonio R Parrado; Kristina Mullin; Wai-Ki Yip; Tian Liu; Johannes T Roehr; Dandi Qiao; Frank Jessen; Oliver Peters; Tim Becker; Alfredo Ramirez; Christoph Lange; Lars Bertram; Rudolph E Tanzi
Journal:  Neurology       Date:  2014-09-03       Impact factor: 9.910

3.  Validating predicted biological effects of Alzheimer's disease associated SNPs using CSF biomarker levels.

Authors:  John S K Kauwe; Carlos Cruchaga; Sarah Bertelsen; Kevin Mayo; Wayne Latu; Petra Nowotny; Anthony L Hinrichs; Anne M Fagan; David M Holtzman; Alison M Goate
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

4.  TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease.

Authors:  Cyril Pottier; David Wallon; Stephane Rousseau; Anne Rovelet-Lecrux; Anne-Claire Richard; Adeline Rollin-Sillaire; Thierry Frebourg; Dominique Campion; Didier Hannequin
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

5.  TREM2 analysis and increased risk of Alzheimer's disease.

Authors:  Deana Finelli; Sara Rollinson; Jenny Harris; Matthew Jones; Anna Richardson; Alex Gerhard; Julie Snowden; David Mann; Stuart Pickering-Brown
Journal:  Neurobiol Aging       Date:  2014-08-27       Impact factor: 4.673

6.  Analysis of protein-coding genetic variation in 60,706 humans.

Authors:  Monkol Lek; Konrad J Karczewski; Eric V Minikel; Kaitlin E Samocha; Eric Banks; Timothy Fennell; Anne H O'Donnell-Luria; James S Ware; Andrew J Hill; Beryl B Cummings; Taru Tukiainen; Daniel P Birnbaum; Jack A Kosmicki; Laramie E Duncan; Karol Estrada; Fengmei Zhao; James Zou; Emma Pierce-Hoffman; Joanne Berghout; David N Cooper; Nicole Deflaux; Mark DePristo; Ron Do; Jason Flannick; Menachem Fromer; Laura Gauthier; Jackie Goldstein; Namrata Gupta; Daniel Howrigan; Adam Kiezun; Mitja I Kurki; Ami Levy Moonshine; Pradeep Natarajan; Lorena Orozco; Gina M Peloso; Ryan Poplin; Manuel A Rivas; Valentin Ruano-Rubio; Samuel A Rose; Douglas M Ruderfer; Khalid Shakir; Peter D Stenson; Christine Stevens; Brett P Thomas; Grace Tiao; Maria T Tusie-Luna; Ben Weisburd; Hong-Hee Won; Dongmei Yu; David M Altshuler; Diego Ardissino; Michael Boehnke; John Danesh; Stacey Donnelly; Roberto Elosua; Jose C Florez; Stacey B Gabriel; Gad Getz; Stephen J Glatt; Christina M Hultman; Sekar Kathiresan; Markku Laakso; Steven McCarroll; Mark I McCarthy; Dermot McGovern; Ruth McPherson; Benjamin M Neale; Aarno Palotie; Shaun M Purcell; Danish Saleheen; Jeremiah M Scharf; Pamela Sklar; Patrick F Sullivan; Jaakko Tuomilehto; Ming T Tsuang; Hugh C Watkins; James G Wilson; Mark J Daly; Daniel G MacArthur
Journal:  Nature       Date:  2016-08-18       Impact factor: 49.962

7.  Assessment of the genetic variance of late-onset Alzheimer's disease.

Authors:  Perry G Ridge; Kaitlyn B Hoyt; Kevin Boehme; Shubhabrata Mukherjee; Paul K Crane; Jonathan L Haines; Richard Mayeux; Lindsay A Farrer; Margaret A Pericak-Vance; Gerard D Schellenberg; John S K Kauwe
Journal:  Neurobiol Aging       Date:  2016-03-03       Impact factor: 4.673

8.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.

Authors:  J C Lambert; C A Ibrahim-Verbaas; D Harold; A C Naj; R Sims; C Bellenguez; A L DeStafano; J C Bis; G W Beecham; B Grenier-Boley; G Russo; T A Thorton-Wells; N Jones; A V Smith; V Chouraki; C Thomas; M A Ikram; D Zelenika; B N Vardarajan; Y Kamatani; C F Lin; A Gerrish; H Schmidt; B Kunkle; M L Dunstan; A Ruiz; M T Bihoreau; S H Choi; C Reitz; F Pasquier; C Cruchaga; D Craig; N Amin; C Berr; O L Lopez; P L De Jager; V Deramecourt; J A Johnston; D Evans; S Lovestone; L Letenneur; F J Morón; D C Rubinsztein; G Eiriksdottir; K Sleegers; A M Goate; N Fiévet; M W Huentelman; M Gill; K Brown; M I Kamboh; L Keller; P Barberger-Gateau; B McGuiness; E B Larson; R Green; A J Myers; C Dufouil; S Todd; D Wallon; S Love; E Rogaeva; J Gallacher; P St George-Hyslop; J Clarimon; A Lleo; A Bayer; D W Tsuang; L Yu; M Tsolaki; P Bossù; G Spalletta; P Proitsi; J Collinge; S Sorbi; F Sanchez-Garcia; N C Fox; J Hardy; M C Deniz Naranjo; P Bosco; R Clarke; C Brayne; D Galimberti; M Mancuso; F Matthews; S Moebus; P Mecocci; M Del Zompo; W Maier; H Hampel; A Pilotto; M Bullido; F Panza; P Caffarra; B Nacmias; J R Gilbert; M Mayhaus; L Lannefelt; H Hakonarson; S Pichler; M M Carrasquillo; M Ingelsson; D Beekly; V Alvarez; F Zou; O Valladares; S G Younkin; E Coto; K L Hamilton-Nelson; W Gu; C Razquin; P Pastor; I Mateo; M J Owen; K M Faber; P V Jonsson; O Combarros; M C O'Donovan; L B Cantwell; H Soininen; D Blacker; S Mead; T H Mosley; D A Bennett; T B Harris; L Fratiglioni; C Holmes; R F de Bruijn; P Passmore; T J Montine; K Bettens; J I Rotter; A Brice; K Morgan; T M Foroud; W A Kukull; D Hannequin; J F Powell; M A Nalls; K Ritchie; K L Lunetta; J S Kauwe; E Boerwinkle; M Riemenschneider; M Boada; M Hiltuenen; E R Martin; R Schmidt; D Rujescu; L S Wang; J F Dartigues; R Mayeux; C Tzourio; A Hofman; M M Nöthen; C Graff; B M Psaty; L Jones; J L Haines; P A Holmans; M Lathrop; M A Pericak-Vance; L J Launer; L A Farrer; C M van Duijn; C Van Broeckhoven; V Moskvina; S Seshadri; J Williams; G D Schellenberg; P Amouyel
Journal:  Nat Genet       Date:  2013-10-27       Impact factor: 38.330

9.  R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia.

Authors:  Catherine F Slattery; Jonathan A Beck; Lorna Harper; Gary Adamson; Zeinab Abdi; James Uphill; Tracy Campbell; Ron Druyeh; Colin J Mahoney; Jonathan D Rohrer; Janna Kenny; Jessica Lowe; Kelvin K Leung; Josephine Barnes; Shona L Clegg; Melanie Blair; Jennifer M Nicholas; Rita J Guerreiro; James B Rowe; Claudia Ponto; Inga Zerr; Hans Kretzschmar; Pierluigi Gambetti; Sebastian J Crutch; Jason D Warren; Martin N Rossor; Nick C Fox; John Collinge; Jonathan M Schott; Simon Mead
Journal:  Alzheimers Dement       Date:  2014-08-23       Impact factor: 21.566

10.  Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation.

Authors:  Joshua C Bis; Xueqiu Jian; Brian W Kunkle; Yuning Chen; Adam C Naj; Myriam Fornage; Lindsay A Farrer; Kara L Hamilton-Nelson; William S Bush; William J Salerno; Daniel Lancour; Yiyi Ma; Alan E Renton; Edoardo Marcora; John J Farrell; Yi Zhao; Liming Qu; Shahzad Ahmad; Najaf Amin; Philippe Amouyel; Gary W Beecham; Jennifer E Below; Dominique Campion; Laura Cantwell; Camille Charbonnier; Jaeyoon Chung; Paul K Crane; Carlos Cruchaga; L Adrienne Cupples; Jean-François Dartigues; Stéphanie Debette; Jean-François Deleuze; Lucinda Fulton; Stacey B Gabriel; Emmanuelle Genin; Richard A Gibbs; Alison Goate; Benjamin Grenier-Boley; Namrata Gupta; Jonathan L Haines; Aki S Havulinna; Seppo Helisalmi; Mikko Hiltunen; Daniel P Howrigan; M Arfan Ikram; Jaakko Kaprio; Jan Konrad; Amanda Kuzma; Eric S Lander; Mark Lathrop; Terho Lehtimäki; Honghuang Lin; Kari Mattila; Richard Mayeux; Donna M Muzny; Waleed Nasser; Benjamin Neale; Kwangsik Nho; Gaël Nicolas; Devanshi Patel; Margaret A Pericak-Vance; Markus Perola; Bruce M Psaty; Olivier Quenez; Farid Rajabli; Richard Redon; Christiane Reitz; Anne M Remes; Veikko Salomaa; Chloe Sarnowski; Helena Schmidt; Michael Schmidt; Reinhold Schmidt; Hilkka Soininen; Timothy A Thornton; Giuseppe Tosto; Christophe Tzourio; Sven J van der Lee; Cornelia M van Duijn; Otto Valladares; Badri Vardarajan; Li-San Wang; Weixin Wang; Ellen Wijsman; Richard K Wilson; Daniela Witten; Kim C Worley; Xiaoling Zhang; Celine Bellenguez; Jean-Charles Lambert; Mitja I Kurki; Aarno Palotie; Mark Daly; Eric Boerwinkle; Kathryn L Lunetta; Anita L Destefano; Josée Dupuis; Eden R Martin; Gerard D Schellenberg; Sudha Seshadri
Journal:  Mol Psychiatry       Date:  2018-08-14       Impact factor: 15.992

View more
  5 in total

1.  WASP family proteins: Molecular mechanisms and implications in human disease.

Authors:  Daniel A Kramer; Hannah K Piper; Baoyu Chen
Journal:  Eur J Cell Biol       Date:  2022-06-01       Impact factor: 6.020

Review 2.  Functional and Phenotypic Diversity of Microglia: Implication for Microglia-Based Therapies for Alzheimer's Disease.

Authors:  Yi-Jun Xu; Ngan Pan Bennett Au; Chi Him Eddie Ma
Journal:  Front Aging Neurosci       Date:  2022-05-26       Impact factor: 5.702

3.  Deletion of Abi3 gene locus exacerbates neuropathological features of Alzheimer's disease in a mouse model of Aβ amyloidosis.

Authors:  Hande Karahan; Daniel C Smith; Byungwook Kim; Luke C Dabin; Md Mamun Al-Amin; H R Sagara Wijeratne; Taylor Pennington; Gonzalo Viana di Prisco; Brianne McCord; Peter Bor-Chian Lin; Yuxin Li; Junmin Peng; Adrian L Oblak; Shaoyou Chu; Brady K Atwood; Jungsu Kim
Journal:  Sci Adv       Date:  2021-11-03       Impact factor: 14.136

4.  PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer's disease.

Authors:  Andy P Tsai; Chuanpeng Dong; Peter Bor-Chian Lin; Evan J Messenger; Brad T Casali; Miguel Moutinho; Yunlong Liu; Adrian L Oblak; Bruce T Lamb; Gary E Landreth; Stephanie J Bissel; Kwangsik Nho
Journal:  Genome Med       Date:  2022-02-18       Impact factor: 11.117

5.  Identification and Quantitation of Novel ABI3 Isoforms Relative to Alzheimer's Disease Genetics and Neuropathology.

Authors:  Andrew K Turner; Benjamin C Shaw; James F Simpson; Steven Estus
Journal:  Genes (Basel)       Date:  2022-09-08       Impact factor: 4.141

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.